1. Home
  2. SCNI vs JAGX Comparison

SCNI vs JAGX Comparison

Compare SCNI & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$0.94

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$1.19

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCNI
JAGX
Founded
2003
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
3.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCNI
JAGX
Price
$0.94
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$60.00
AVG Volume (30 Days)
41.7K
380.3K
Earning Date
11-24-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$1,147,000.00
$11,785,000.00
Revenue This Year
N/A
$22.41
Revenue Next Year
N/A
$30.00
P/E Ratio
$4.55
N/A
Revenue Growth
303.87
12.45
52 Week Low
$0.86
$1.00
52 Week High
$6.18
$33.25

Technical Indicators

Market Signals
Indicator
SCNI
JAGX
Relative Strength Index (RSI) 38.13 41.39
Support Level $1.14 $1.05
Resistance Level $1.26 $1.36
Average True Range (ATR) 0.10 0.16
MACD 0.02 0.04
Stochastic Oscillator 13.13 38.00

Price Performance

Historical Comparison
SCNI
JAGX

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: